Showing results (31-40 of 203) with videos related to
Sort By:
Pageof 21
International Journal of Technology Assessment in Health Care|March 2, 2005
Meta-analysis when only the median survival times are known: a comparison with individual patient data resultsStefan Michiels, Pascal Piedbois, Sarah Burdett, et al.Statistical Methods in Medical Research|February 21, 2008
Individual- and trial-level surrogacy in colorectal cancerMarc Buyse, Tomasz Burzykowski, Stefan Michiels, et al.Current Opinion in Oncology|January 1, 2005
Challenges in breast cancer clinical trial design in the postgenomic eraSherene Loi, Marc Buyse, Christos Sotiriou, et al.Statistical Methods in Medical Research|June 17, 2004
A perspective on surrogate endpoints in controlled clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Is FOB screening really the answer for lowering mortality in colorectal cancer?Philippe Autier, Peter Boyle, Marc Buyse, et al.Statistics in Medicine|January 30, 2015
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkersLili Zhao, Dai Feng, Brian Neelon, et al.International Journal of Clinical Oncology|June 25, 2020
Central statistical monitoring of investigator-led clinical trials in oncologyMarc Buyse, Laura Trotta, Everardo D Saad, et al.Clinical Trials (London, England)|July 27, 2019
Open science: The open clinical trials data journeyFrank Rockhold, Christina Bromley, Erin K Wagner, et al.Pharmaceutical Statistics|September 10, 2021
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpointLeandro Garcia Barrado, Tomasz Burzykowski, Catherine Legrand, et al.Nature Reviews. Clinical Oncology|February 8, 2017
Precision medicine needs randomized clinical trialsEverardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.Pageof 21